Combined translocation with ZNF198-FGFR1 gene fusion and deletion of potential tumor suppressors in a myeloproliferative disorder

被引:17
作者
Etienne, Anne
Gelsi-Boyer, Veronique
Carbuccia, Nadine
Adelaide, Jose
Barba, Gianluca
La Starza, Roberta
Murati, Anne
Eclache, Virginie
Birg, Francoise
Birnbaum, Daniel
Mozziconacci, Marie-Joelle
Mecucci, Cristina
Chaffanet, Max
机构
[1] INSERM, Inst J Paoli I Calmettes, Ctr Rech Cancerol, Dept Oncol Mol & Hematol Mol,UMR 599, F-13009 Marseille, France
[2] Univ Perugia, Dept Hematol, Policlin Monteluce, I-06123 Perugia, Italy
[3] Hop Avicenne, Hematol Lab, F-93000 Bobigny, France
关键词
D O I
10.1016/j.cancergencyto.2006.10.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tyrosine kinases activated by mutation or translocation are involved in the chronic phase of myeloproliferative disorders. Complementary or alternative events are not so well characterized. We report here a case of t(8;13) generating a ZNF198-FGFR1 fusion kinase gene on the derivative chromosome 13. ZNF198-FGFR1 mRNA, but not FGFR1-ZNF198, was detected by polymerase chain reaction amplification. By using fluorescence in situ hybridization with BAC clones, we mapped a deletion of about 2 megabases on the derivative chromosome 8, including the reciprocal FGFR1-ZNF198 fusion gene and the surrounding genes from 8p11 and 13q12. Potential tumor suppressor genes affected by the deletion by loss (IFT88, CRYLI, TACCI) or break (LATS2) may participate in the malignant process. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:154 / 158
页数:5
相关论文
共 13 条
  • [1] LATS2-Ajuba complex regulates γ-tubulin recruitment to centrosomes and spindle organization during mitosis
    Abe, Y
    Ohsugi, M
    Haraguchi, K
    Fujimoto, J
    Yamamoto, T
    [J]. FEBS LETTERS, 2006, 580 (03): : 782 - 788
  • [2] The IL-17 cytokine family members are inhibitors of human hematopoletic progenitor proliferation
    Broxmeyer, Hal E.
    Starnes, Trevor
    Ramsey, Heather
    Cooper, Scott
    Dahl, Richard
    Williamson, Elizabeth
    Hromas, Robert
    [J]. BLOOD, 2006, 108 (02) : 770 - 770
  • [3] Molecular genetic evidence supporting a novel human hepatocellular carcinoma tumor suppressor locus at 13q 12.11
    Chen, CF
    Yeh, SH
    Chen, DS
    Chen, PJ
    Jou, YS
    [J]. GENES CHROMOSOMES & CANCER, 2005, 44 (03) : 320 - 328
  • [4] Chronic myeloproliferative disorders: a tyrosine kinase tale
    De Keersmaecker, K
    Cools, J
    [J]. LEUKEMIA, 2006, 20 (02) : 200 - 205
  • [5] Myeloproliferative disorders:: the centrosome connection
    Delaval, B
    Lelièvre, H
    Birnbaum, D
    [J]. LEUKEMIA, 2005, 19 (10) : 1739 - 1744
  • [6] Double jeopardy from a single translocation: deletions of the derivative chromosome 9 in chronic myeloid leukemia
    Huntly, BJP
    Bench, A
    Green, AR
    [J]. BLOOD, 2003, 102 (04) : 1160 - 1168
  • [7] Downregulation of the large tumor suppressor 2 (LATS2/KPM) gene is associated with poor prognosis in acute lymphoblastic leukemia
    Jiménez-Velasco, A
    Román-Gómez, J
    Agirre, X
    Barrios, M
    Navarro, G
    Vázquez, I
    Prósper, F
    Torres, A
    Heiniger, A
    [J]. LEUKEMIA, 2005, 19 (12) : 2347 - 2350
  • [8] Myeloproliferative disorders: premalignant, stem cell, G1 diseases?
    Lelievre, H.
    Ferrand, A.
    Mozziconacci, M-J
    Birnbaum, D.
    Delaval, B.
    [J]. LEUKEMIA, 2006, 20 (09) : 1475 - 1480
  • [9] Lats2, a putative tumor suppressor, inhibits G1/S transition
    Li, YF
    Pei, J
    Xia, H
    Ke, HN
    Wang, HY
    Tao, WF
    [J]. ONCOGENE, 2003, 22 (28) : 4398 - 4405
  • [10] Lats2/Kpm is required for embryonic development, proliferation control and genomic integrity
    McPherson, JP
    Tamblyn, L
    Elia, A
    Migon, E
    Shehabeldin, A
    Matysiak-Zablocki, E
    Lemmers, B
    Salmena, L
    Hakem, A
    Fish, J
    Kassam, F
    Squire, J
    Bruneau, BG
    Hande, MP
    Hakem, R
    [J]. EMBO JOURNAL, 2004, 23 (18) : 3677 - 3688